HST GENOMICS (a specialized business division under HST) is a leading global provider of high-throughput sequencing services, multi-omics research solutions, and advanced molecular diagnostic platforms. With high-throughput sequencing, mass spectrometry, single-cell spatial technology, and laboratory automation as our core pillars, we deliver comprehensive, closed-loop multi-omics solutions for life science research, clinical translation, agricultural breeding, and biopharmaceutical development.
We host a top-tier team of scientists and bioinformaticians, operating state-of-the-art sequencing and mass spectrometry hardware ecosystems. Through deep integration of machine learning and multi-omics data computing, HST GENOMICS provides high-quality services including Whole Genome/Exome Sequencing, Single-Cell RNA-Seq, Spatial Transcriptomics, Quantitative Proteomics, and Metabolomics. We serve over 1,000 academic institutions, medical centers, and biopharma partners globally, accelerating the frontier of life science and precision medicine.
Focusing on genetic technology and molecular diagnostics, HST GENOMICS drives pathogen detection technology to the forefront with hard-core innovation
Obtained ISO 9001 and ISO 13485 quality management system certifications, standardizing bioinformatics analysis and R&D pipelines.
Won the 2nd prize in the 7th China Medical Device Innovation Competition (In Vitro Diagnostics Finals) and honored with the "Innovative SME" title.
Formally established the HST GENOMICS division in Longgang District as a key government-attracted project; established a joint industry-university-research conversion center with the Chinese University of Hong Kong (Shenzhen).
Signed a strategic investment and cooperation framework agreement with Longgang District government; selected as top 9 in the Illumina Sequoia China Intelligent Medical Genomics Incubator.
Formally released the HST® host nucleic acid filter; won the championship of the 10th China Innovation and Entrepreneurship Competition (Bio-Medicine Growth Group).
Focused on sample pre-processing bottleneck, launching overall R&D solutions for high-efficiency host nucleic acid depletion and target enrichment.
Awarded the National High-Tech Enterprise certification; actively participated in community welfare projects with Alxa SEE Foundation and Green Bud Foundation.
Collaborated with China Life, Ping An, and ZGC Biobank; secured multiple patents and software copyrights in molecular diagnostics.
Guangzhou Health Gene Tech Co., Ltd. established in Guangzhou International Bio Island as a key project, co-building the medical testing laboratory.